Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 112
Filter
Add more filters










Publication year range
1.
Connect Tissue Res ; 44 Suppl 1: 298-9, 2003.
Article in English | MEDLINE | ID: mdl-12952212

ABSTRACT

To study whether eruption of teeth and root growth require remodeling of collagen in the peridental tissues, we studied molar development in mice deficient in MT1-MMP, an enzyme essential for remodeling of soft tissue-hard tissue interfaces. The lower jaws of deficient mice and their wildtype littermates were subjected to stereologic analysis. It was shown that in deficient animals, eruption and root elongation were severely inhibited, signifying a role of the enzyme in these developmental processes.


Subject(s)
Metalloendopeptidases/metabolism , Periodontal Ligament/enzymology , Tooth Eruption/physiology , Tooth Root/enzymology , Animals , Bone Remodeling/physiology , Calcification, Physiologic/physiology , Fibrillar Collagens/metabolism , Matrix Metalloproteinase 14 , Matrix Metalloproteinases, Membrane-Associated , Metalloendopeptidases/deficiency , Metalloendopeptidases/genetics , Mice , Mice, Knockout , Molar/enzymology , Molar/growth & development , Periodontal Ligament/cytology , Tooth Root/cytology , Tooth Root/growth & development
2.
J Cell Biol ; 155(7): 1333-44, 2001 Dec 24.
Article in English | MEDLINE | ID: mdl-11748248

ABSTRACT

Tissue-remodeling processes are largely mediated by members of the matrix metalloproteinase (MMP) family of endopeptidases whose expression is strictly controlled both spatially and temporally. In this article, we have examined the molecular mechanisms that could contribute to modulate the expression of MMPs like collagenase-3 and MT1-MMP during bone formation. We have found that all-trans retinoic acid (RA), which usually downregulates MMPs, strongly induces collagenase-3 expression in cultures of embryonic metatarsal cartilage rudiments and in chondrocytic cells. This effect is dose and time dependent, requires the de novo synthesis of proteins, and is mediated by RAR-RXR heterodimers. Analysis of the signal transduction mechanisms underlying the upregulating effect of RA on collagenase-3 expression demonstrated that this factor acts through a signaling pathway involving p38 mitogen-activated protein kinase. RA treatment of chondrocytic cells also induces the production of MT1-MMP, a membrane-bound metalloproteinase essential for skeletal formation, which participates in a proteolytic cascade with collagenase-3. The production of these MMPs is concomitant with the development of an RA-induced differentiation program characterized by formation of a mineralized bone matrix, downregulation of chondrocyte markers like type II collagen, and upregulation of osteoblastic markers such as osteocalcin. These effects are attenuated in metatarsal rudiments in which RA induces the invasion of perichondrial osteogenic cells from the perichondrium into the cartilage rudiment. RA treatment also resulted in the upregulation of Cbfa1, a transcription factor responsible for collagenase-3 and osteocalcin induction in osteoblastic cells. The dynamics of Cbfa1, MMPs, and osteocalcin expression is consistent with the fact that these genes could be part of a regulatory cascade initiated by RA and leading to the induction of Cbfa1, which in turn would upregulate the expression of some of their target genes like collagenase-3 and osteocalcin.


Subject(s)
Bone Development/physiology , Chondrocytes/metabolism , MAP Kinase Signaling System/physiology , Matrix Metalloproteinases/metabolism , Neoplasm Proteins , Osteogenesis , Transcription Factors/metabolism , Tretinoin/pharmacology , Animals , Cell Differentiation , Chondrocytes/cytology , Collagenases/genetics , Core Binding Factor Alpha 1 Subunit , Embryonic and Fetal Development , Enzyme Activation , Matrix Metalloproteinase 1/deficiency , Matrix Metalloproteinase 1/genetics , Matrix Metalloproteinase 13 , Metatarsus , Mice , Mice, Knockout
3.
Lab Invest ; 81(10): 1403-14, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11598153

ABSTRACT

The urokinase plasminogen activator receptor-associated protein/Endo180 (uPARAP/Endo180) is a newly discovered member of the macrophage mannose receptor family that was reported to interact with ligand-bound urokinase plasminogen activator receptor (uPAR), matrix metalloprotease-13 (MMP-13), and collagen V on the cell surface. We have determined the sites of expression of this novel receptor during murine postimplantation development. uPARAP/Endo180 was expressed in all tissues undergoing primary ossification, including the developing bones of the viscerocranium and calvarium that ossify intramembranously, and developing long bones undergoing endochondral ossification. uPARAP/Endo180 mRNA was expressed by both immature osteoblasts and by mature osteocalcin-producing osteoblasts-osteocytes, and was coexpressed with MMP-13. Interestingly, osteoblasts also expressed uPAR. Besides bone-forming tissues, uPARAP/Endo180 expression was detected only in a mesenchymal condensation of the midbrain and in the developing lungs. The data suggest a function of this novel protease receptor in bone development, possibly mediated through its interactions with uPAR, MMP-13, or collagen V.


Subject(s)
Bone and Bones/physiology , Collagenases/biosynthesis , Receptors, Cell Surface/biosynthesis , Receptors, Mitogen/biosynthesis , Animals , Bone and Bones/embryology , Embryonic and Fetal Development , Female , Immunohistochemistry , Matrix Metalloproteinase 13 , Mice , Osteogenesis/physiology , Pregnancy , Receptors, Urokinase Plasminogen Activator
4.
Tissue Eng ; 7(4): 405-13, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11506730

ABSTRACT

Extreme salivary hypofunction is a result of tissue damage caused by irradiation therapy for cancer in the head and neck region. Unfortunately, there is no currently satisfactory treatment for this condition that affects up to 40,000 people in the United States every year. As a novel approach to managing this problem, we are attempting to develop an orally implantable, fluid-secreting device (an artificial salivary gland). We are using the well-studied HSG salivary cell line as a potential allogeneic graft cell for this device. One drawback of using a cell line is the potential for malignant transformation. If such an untoward response occurred, the device could be removed. However, in the event that any HSG cells escaped, we wished to provide additional patient protection. Accordingly, we have engineered HSG cells with a hybrid adeno-retroviral vector, AdLTR.CMV-tk, to express the herpes simplex virus thymidine kinase (HSV-tk) suicide gene as a novel safety factor. Cells were grown on plastic plates or on poly-L-lactic acid disks and then transduced with different multiplicities of infection (MOIs) of the hybrid vector. Thereafter, various concentrations of ganciclovir (GCV) were added, and cell viability was tested. Transduced HSG cells expressed HSV-tk and were sensitive to GCV treatment. Maximal effects were seen at a MOI of 10 with 50 microM of GCV, achieving 95% cell killing on the poly-L-lactic acid substrate. These results suggest that engineering the expression of a suicide gene in an allogeneic graft cell may provide additional safety for use in an artificial salivary gland device.


Subject(s)
Artificial Organs , Cell Line , Salivary Glands/transplantation , Tissue Engineering , Bioprosthesis , Genetic Vectors , Humans , Simplexvirus , Thymidine Kinase/genetics , Transplantation, Homologous
5.
Matrix Biol ; 20(3): 193-203, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11420151

ABSTRACT

The respective requirements of collagen and MT1-MMP in the activation of MMP-2 by primary fibroblast cultures were explored further. Three-dimensional gels enriched in human collagen types I and III or composed of recombinant human type II or III collagen, caused increased MT1-MMP production (mRNA and protein) and induced MMP-2 activation. Only marginal induction was seen with dried monomeric collagen confirming the need for collagen fibrillar organisation for activation. To our surprise, relatively low amounts (as low as 25 microg/ml) of acid soluble type I collagen added to fibroblast cultures also induced potent MMP-2 activation. However, the requirement for collagen fibril formation by the added collagen was indicated by the inhibition seen when the collagen was pre-incubated with a fibril-blocking peptide, and the reduced activation seen with alkali-treated collagen preparations known to have impaired fibrilisation. Pre-treatment of the collagen with sodium periodate also abrogated MMP-2 activation induction. Further evidence of the requirement for collagen fibril formation was provided by the lack of activation when type IV collagen, which does not form collagen fibrils, was added in the cultures. Fibroblasts derived from MT1-MMP-deficient mice were unable to activate MMP-2 in response to either three-dimensional collagen gel or added collagen solutions, compared to their littermate controls. Collectively, these data indicate that the fibrillar structure of collagen and MT1-MMP are essential for the MMP-2 activational response in fibroblasts.


Subject(s)
Collagen/metabolism , Matrix Metalloproteinase 2/metabolism , Metalloendopeptidases/metabolism , Animals , Enzyme Activation , Fibroblasts/cytology , Gene Expression , Humans , Matrix Metalloproteinase 14 , Matrix Metalloproteinases, Membrane-Associated , Mice , Skin/cytology
6.
J Biol Chem ; 276(22): 19027-32, 2001 Jun 01.
Article in English | MEDLINE | ID: mdl-11259424

ABSTRACT

Membrane type 1-matrix metalloproteinase (MT1-MMP)-mediated activation of MMP-2 is thought to be important in the proteolysis of extracellular matrix in pathological events in which monocytes/macrophages are found. Here we report on the induction and regulation of human monocyte MT1-MMP and its role in MMP-2 activation. Activation of monocytes by lipopolysaccharide resulted in the induction of MT1-MMP mRNA and protein that was suppressed by inhibitors of prostaglandin synthesis (indomethacin), adenylyl cyclase (SQ 22536), and protein kinase A (Rp-cAMPs). Suppression of MT1-MMP by indomethacin and SQ 22536 was reversed by prostaglandin E(2) and dibutyryl cyclic AMP, respectively, demonstrating that induction of monocyte MT1-MMP is regulated through a prostaglandin-cAMP pathway. Functional analysis revealed that pro-MMP-2 in the supernatants from human bone marrow stromal fibroblasts, normal male-derived fibroblasts and melanoma cells (A2058) was converted to active MMP-2 when cultured with activated but not control monocytes. Antibodies against MT1-MMP blocked the activation of MMP-2. Tissue inhibitor of metalloproteinase-2 regulation of MMP-2 activation was shown through the addition of varying amounts of recombinant tissue inhibitor of metalloproteinase-2 with pro-MMP-2 to MT1-MMP-expressing monocytes. These findings demonstrate that activated monocytes express functionally active MT1-MMP that may play a significant role in the activation of MMP-2 produced by other cells and as such influence developmental and pathological conditions.


Subject(s)
Adenine/analogs & derivatives , Matrix Metalloproteinase 2/metabolism , Metalloendopeptidases/chemistry , Metalloendopeptidases/physiology , Monocytes/enzymology , Prostaglandins/metabolism , Adenine/pharmacology , Adenylyl Cyclases/metabolism , Adenylyl Cyclases/pharmacology , Blotting, Western , Bucladesine/pharmacology , Cells, Cultured , Cyclic AMP/metabolism , Cyclic AMP-Dependent Protein Kinases/antagonists & inhibitors , Cyclic AMP-Dependent Protein Kinases/pharmacology , Dinoprostone/metabolism , Enzyme Activation , Enzyme Inhibitors/pharmacology , Fibroblasts/metabolism , Flow Cytometry , Humans , Indomethacin/pharmacology , Lipopolysaccharides/pharmacology , Matrix Metalloproteinases, Membrane-Associated , Monocytes/metabolism , RNA/metabolism , Tissue Inhibitor of Metalloproteinase-2/metabolism , Tissue Inhibitor of Metalloproteinase-2/physiology
7.
Mol Biol Rep ; 27(2): 73-9, 2000 Jun.
Article in English | MEDLINE | ID: mdl-11092553

ABSTRACT

Using homology-based database screening, we have identified the mouse homologue for the recently described matrix metalloproteinase-19 (MMP-19). Sequencing of mouse MMP-19 resulted in a putative open reading frame (ORF) of 527 amino acids showing 84% identity to the human homologue. In mouse, MMP-19 appears to be most highly expressed in the liver; however, there is a detectable level of expression in all tissues analyzed. The major mouse MMP-19 transcript is almost twice as long as that of human. The COOH-terminal serine and threonine-rich domain is considerably longer in the mouse homologue. The mouse MMP-19 gene maps to very distal end of mouse chromosome 10.


Subject(s)
Gene Expression Regulation, Enzymologic , Metalloendopeptidases/genetics , Metalloendopeptidases/metabolism , Amino Acid Sequence , Animals , Base Sequence , Catalytic Domain , Chromosome Mapping , Cloning, Molecular , Humans , Liver/physiology , Matrix Metalloproteinases, Secreted , Mice , Mice, Inbred Strains , Molecular Sequence Data , Sequence Analysis , Sequence Homology, Amino Acid
8.
Cancer Res ; 60(21): 6061-7, 2000 Nov 01.
Article in English | MEDLINE | ID: mdl-11085528

ABSTRACT

Matrix metalloproteinases (MMPs) are overexpressed in a variety of tumor tissues and cell lines, and their expression is highly correlated to tumor invasion and metastasis. To exploit these characteristics in the design of tumor cell-selective cytotoxins, we constructed two mutated anthrax toxin protective antigen (PA) proteins in which the furin protease cleavage site is replaced by sequences selectively cleaved by MMPs. These MMP-targeted PA proteins were activated rapidly and selectively on the surface of MMP-overexpressing tumor cells. The activated PA proteins caused internalization of a recombinant cytotoxin, FP59, consisting of anthrax toxin lethal factor residues 1-254 fused to the ADP-ribosylation domain of Pseudomonas exotoxin A. The toxicity of the mutated PA proteins for MMP-overexpressing cells was blocked by hydroxamate inhibitors of MMPs, including BB94, and by a tissue inhibitor of matrix metalloproteinases (TIMP-2). The mutated PA proteins killed MMP-overexpressing tumor cells while sparing nontumorigenic normal cells when these were grown together in a coculture model, indicating that PA activation occurred on the tumor cell surface and not in the supernatant. This method of achieving cell-type specificity is conceptually distinct from, and potentially synergistic with, the more common strategy of retargeting a protein toxin by fusion to a growth factor, cytokine, or antibody.


Subject(s)
Antigens, Bacterial , Bacterial Toxins/pharmacokinetics , Bacterial Toxins/toxicity , Matrix Metalloproteinases/metabolism , Amino Acid Sequence , Animals , Bacterial Toxins/genetics , Binding Sites , Biotransformation , Breast Neoplasms/drug therapy , Breast Neoplasms/enzymology , COS Cells/enzymology , Chlorocebus aethiops , Coculture Techniques , Fibrosarcoma/drug therapy , Fibrosarcoma/enzymology , Humans , Matrix Metalloproteinase 2/biosynthesis , Matrix Metalloproteinase 2/metabolism , Matrix Metalloproteinase 9/biosynthesis , Matrix Metalloproteinase 9/metabolism , Matrix Metalloproteinases/biosynthesis , Matrix Metalloproteinases, Membrane-Associated , Melanoma/drug therapy , Melanoma/enzymology , Metalloendopeptidases/biosynthesis , Metalloendopeptidases/metabolism , Mutation , Tumor Cells, Cultured , Vero Cells/enzymology
9.
J Dent Res ; 79(9): 1697-703, 2000 Sep.
Article in English | MEDLINE | ID: mdl-11023266

ABSTRACT

Enamelysin is a recently isolated member of the matrix metalloproteinase (MMP) family of extracellular matrix (ECM)-degrading enzymes. Here we describe the isolation and characterization of the mouse enamelysin cDNA. Expression of mouse enamelysin was detectable only in ameloblasts and odontoblasts of developing teeth. Characterization of mouse enamelysin demonstrated that it is highly conserved in both its sequence content and pattern of expression relative to the porcine, human, and bovine homologues previously described.


Subject(s)
Cloning, Molecular/methods , Gene Expression Regulation, Enzymologic/genetics , Matrix Metalloproteinases/genetics , Amino Acid Sequence , Animals , Base Sequence , Blotting, Northern/methods , Cattle , DNA, Complementary/genetics , Humans , In Situ Hybridization/methods , Matrix Metalloproteinase 20 , Mice , Molar/enzymology , Molecular Sequence Data , Polymerase Chain Reaction/methods , Sequence Analysis, DNA , Sequence Homology, Amino Acid , Swine
10.
J Biol Chem ; 275(34): 26416-22, 2000 Aug 25.
Article in English | MEDLINE | ID: mdl-10827176

ABSTRACT

To understand the biologic function of TIMP-2, a member of the tissue inhibitors of metalloproteinases family, an inactivating mutation was introduced in the mouse Timp-2 gene by homologous recombination. Outbred homozygous mutants developed and procreated indistinguishably from wild type littermates, suggesting that fertility, development, and growth are not critically dependent on TIMP-2. Lack of functional TIMP-2, however, dramatically altered the activation of proMMP-2 both in vivo and in vitro. Fully functional TIMP-2 is essential for efficient activation of proMMP-2 in vivo. No evidence of successful functional compensation was observed. The results illustrate the duality of TIMP-2 function, i.e. at low concentrations, TIMP-2 exerts a "catalytic" or enhancing effect on cell-mediated proMMP-2 activation, whereas at higher concentrations, TIMP-2 inhibits the activation and/or activity of MMP-2.


Subject(s)
Enzyme Precursors/metabolism , Gelatinases/metabolism , Metalloendopeptidases/metabolism , Tissue Inhibitor of Metalloproteinase-2/genetics , Amino Acid Sequence , Animals , Base Sequence , Cells, Cultured , Enzyme Activation , Female , Male , Mice , Molecular Sequence Data , Mutagenesis, Site-Directed , Protein Structure, Secondary , Recombination, Genetic , Tissue Inhibitor of Metalloproteinase-2/metabolism
12.
Genomics ; 62(2): 308-11, 1999 Dec 01.
Article in English | MEDLINE | ID: mdl-10610728

ABSTRACT

Mouse enamelysin (Mmp20), a member of the matrix metalloproteinase (MMP) family of extracellular matrix degrading enzymes, shows a high degree of homology with other MMPs, particularly those of the stromelysin/collagenase subfamilies. It is expressed exclusively in ameloblasts and odontoblasts. The mouse enamelysin gene (Mmp20) is made up of 10 exons spanning approximately 65 kb within the MMP gene cluster at the centromeric end of chromosome 9.


Subject(s)
Chromosome Mapping , Matrix Metalloproteinases/chemistry , Matrix Metalloproteinases/genetics , Animals , Cloning, Molecular , DNA Primers/chemistry , Exons/genetics , Gene Expression Regulation , Genetic Markers , Introns/genetics , Matrix Metalloproteinase 20 , Matrix Metalloproteinases/biosynthesis , Matrix Metalloproteinases/isolation & purification , Mice , Mice, Inbred C57BL , Molecular Sequence Data , Multigene Family/genetics , Muridae
13.
Cell ; 99(1): 81-92, 1999 Oct 01.
Article in English | MEDLINE | ID: mdl-10520996

ABSTRACT

MT1-MMP is a membrane-bound matrix metalloproteinase (MT-MMP) capable of mediating pericellular proteolysis of extracellular matrix components. MT1-MMP is therefore thought to be an important molecular tool for cellular remodeling of the surrounding matrix. To establish the biological role of this membrane proteinase we generated MT1-MMP-deficient mice by gene targeting. MT1-MMP deficiency causes craniofacial dysmorphism, arthritis, osteopenia, dwarfism, and fibrosis of soft tissues due to ablation of a collagenolytic activity that is essential for modeling of skeletal and extraskeletal connective tissues. Our findings demonstrate the pivotal function of MT1-MMP in connective tissue metabolism, and illustrate that modeling of the soft connective tissue matrix by resident cells is essential for the development and maintenance of the hard tissues of the skeleton.


Subject(s)
Arthritis/genetics , Bone Diseases, Metabolic/genetics , Collagen/metabolism , Connective Tissue Diseases/genetics , Dwarfism/genetics , Matrix Metalloproteinases/genetics , Metalloendopeptidases , Animals , Arthritis/mortality , Arthritis/pathology , Body Constitution , Bone Development , Bone Diseases, Metabolic/mortality , Bone Diseases, Metabolic/pathology , Bone Resorption/pathology , Cachexia/genetics , Cartilage/pathology , Connective Tissue Diseases/mortality , Connective Tissue Diseases/pathology , Disease Models, Animal , Dwarfism/mortality , Dwarfism/pathology , Fibrosis , Growth Plate/pathology , Hyalin , Matrix Metalloproteinase 14 , Matrix Metalloproteinases/metabolism , Matrix Metalloproteinases, Membrane-Associated , Mice , Mice, Knockout , Osteoblasts/enzymology , Osteoblasts/pathology , Skin/cytology , Skin/enzymology , Skull/pathology , Stromal Cells/pathology , Synovial Membrane/pathology
15.
Biochemistry ; 38(4): 1316-22, 1999 Jan 26.
Article in English | MEDLINE | ID: mdl-9930993

ABSTRACT

Human stromelysin-1 (SL-1) is a member of the stromelysin subfamily of matrix metalloproteinases (MMPs). The MMPs play a major role in the degradation of the extracellular matrix (ECM) during normal and pathological conditions. SL-1 like the other MMPs can be activated in vitro by the stepwise removal of the propeptide that contains a single unpaired cysteine which coordinates the active site zinc. Other residues in the propeptide also play a role in maintaining the latency of the enzymes. Deletion mutants and single-site amino acid replacements within the propeptide of a carboxyl-terminally truncated stromelysin-1 (mini-SL-1) were constructed and expressed in Escherichia coli to further examine what amino acids within the propeptide of SL-1 are important for maintaining latency. While the natural enzyme displayed some limited tendency to spontaneously (autolytically) convert to lower Mr in a stepwise manner and finally to the fully processed form, all of the truncation mutants of more than 19 amino acids generated in E. coli showed greatly accelerated self-cleavage indicative of diminished stability and/or resistance to proteolysis of the residual propeptide. Mutant Delta63 as well as other mutants in which most of the propeptide had been deleted no longer responded to exposure to the organomercurial APMA by accelerated autolytic processing. Rather, APMA inhibited the autolytic processing in these mutants, further confirming the complexity of the action of this organomercurial in the activation of pro-MMPs.


Subject(s)
Matrix Metalloproteinase 3/biosynthesis , Matrix Metalloproteinase 3/genetics , Phenylmercuric Acetate/analogs & derivatives , Protein Processing, Post-Translational/drug effects , Amino Acid Sequence , Amino Acid Substitution , Animals , Cloning, Molecular , Escherichia coli , Humans , Male , Matrix Metalloproteinase 3/chemistry , Molecular Sequence Data , Mutagenesis, Site-Directed , Phenylmercuric Acetate/pharmacology , Point Mutation , Rabbits , Rats , Recombinant Proteins/biosynthesis , Recombinant Proteins/metabolism , Sequence Alignment , Sequence Deletion , Sequence Homology, Amino Acid , Sulfhydryl Reagents/pharmacology , Swine
16.
J Periodontal Res ; 33(7): 408-20, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9842506

ABSTRACT

Periodontitis is characterized by advancement of a narrow band of epithelium (1-10 cells wide) through the collagenous periodontal ligament in response to bacterial accumulation and infection. A modulating role by epithelial cells in the progression of periodontitis was hypothesized due to the close proximity of the advancing epithelium to both the etiological bacteria and to the collagen fibers of the ligament. We demonstrate that rat mucosal epithelial cells and human fibroblasts are similarly stimulated to degrade a collagen type I cellular substrate by thiol-dependent activity released by the major periodontal pathogen Porphyromonas gingivalis. A purified, extracellular bacterial thiol-proteinase from P. gingivalis ATCC 33277 stimulated mucosal epithelial cells to upregulate expression of collagenase and stromelysin, and to degrade a collagen type I fibril matrix. Stimulation of the epithelial cells with this purified proteinase was associated with morphological changes in the cells and with accumulation of secreted latent procollagenase throughout the culture medium. Release of active collagenase was minimal and collagen degradation by the epithelial cells was discreet and localized subcellularly suggesting the possibility that activation of secreted procollagenase was cell-associated. We conclude that a collagen-degrading phenotype can be stimulated in relatively quiescent mucosal epithelial cells and fibroblasts by the presence of bacterial proteinase. These experiments suggest roles for the P. gingivalis thiol-proteinase and the epithelial cell in the pathogenesis of periodontal disease and demonstrate the potential for dysregulation of extracellular matrix remodeling events during healing of other bacterially infected wounds.


Subject(s)
Cysteine Endopeptidases/metabolism , Metalloendopeptidases/biosynthesis , Periodontal Ligament/metabolism , Periodontitis/enzymology , Porphyromonas gingivalis/enzymology , Adhesins, Bacterial , Animals , Bacterial Proteins/metabolism , Base Sequence , Cells, Cultured , Collagen/metabolism , Culture Media, Conditioned , Epithelial Cells/metabolism , Extracellular Matrix/metabolism , Fibroblasts/metabolism , Gingipain Cysteine Endopeptidases , Hemagglutinins/metabolism , Humans , Molecular Sequence Data , Mouth Mucosa/metabolism , Periodontal Ligament/cytology , Periodontitis/microbiology , Porphyromonas gingivalis/pathogenicity , RNA, Messenger/analysis , Rats , Up-Regulation
17.
Biochim Biophys Acta ; 1388(1): 21-34, 1998 Oct 14.
Article in English | MEDLINE | ID: mdl-9774703

ABSTRACT

Mutants in the tissue inhibitor of metalloproteinases-1 (TIMP-1) protein have been created by site-directed mutagenesis and expressed in HeLa cells, using a recombinant vaccinia virus system. Removal of either or both glycosylation sites yielded proteins which retained wild-type inhibitory activity against both human fibroblast-type collagenase (FIB-CL) and Mr 72000 gelatinase (GL). However, the double glycosylation mutant protein was expressed at a level that was 2-4-fold lower than that of the wild-type or the single site glycosylation mutants. The 'tiny-TIMP' COOH-terminal deletion mutant that lacks the last 57 residues was also inhibitory, but the dose-response curve suggested that the interaction with the Mr 72000 gelatinase had been altered. A number of replacement mutants in the highly conserved NH2-terminal domain, including replacement of P5A and P8A or a double mutation in the VIRAK sequence which is absolutely conserved in all TIMPs in all species (VIRAK to VIAAA), also yielded functional proteins capable of inhibiting FIB-CL and Mr 72000 GL and of forming SDS-resistant complexes with FIB-CL. None of the above manipulations abolished inhibitory function suggesting that binding of the inhibitor by the enzyme involves multiple interactions.


Subject(s)
Mutation , Tissue Inhibitor of Metalloproteinase-1/genetics , Tissue Inhibitor of Metalloproteinase-1/metabolism , Amino Acid Sequence , Conserved Sequence , Glycosylation , HeLa Cells , Humans , Molecular Sequence Data , Molecular Weight , Mutagenesis, Site-Directed , Recombinant Proteins/biosynthesis , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Sequence Deletion , Tissue Inhibitor of Metalloproteinase-1/biosynthesis , Vaccinia virus/genetics
18.
J Periodontal Res ; 33(5): 280-91, 1998 Jul.
Article in English | MEDLINE | ID: mdl-9777595

ABSTRACT

The classification of periodontitis in various disease categories, including juvenile periodontitis, rapidly progressive adult periodontitis and slowly progressive adult periodontitis is based mainly on differences in disease progression and age group susceptibility. Because dissolution of collagen fibers is an integral part of periodontal attachment loss, we investigated whether the clinical differences among these periodontitis/control groups are reflected in the collagen-degrading activity of gingival fibroblasts isolated from affected tissues. All fibroblast strains isolated from the 4 groups (n = 48) displayed cell-associated collagenolytic activity when seeded in contact with a reconstituted film of type I collagen fibrils. Cells from the control group (n = 14) dissolved the collagen fibril film twice as fast as those from each of the 3 disease groups (juvenile periodontitis (n = 13), rapidly progressive adult periodontitis (n = 7), and slowly progressive adult periodontitis (n = 14)). Both interleukin-1 beta and phorbolester accelerated the rate of dissolution 2-4-fold, but even after cytokine or phorbolester stimulation control cells were still considerably more effective in dissolving the collagen fibrils than cells from the disease groups. The observation made in this study, that dissolution of collagen fibrils by gingival fibroblasts from periodontally diseased individuals is significantly slower than by cells from healthy control subjects, challenges disease paradigms based on a direct relationship between collagenolytic potential and disease activity.


Subject(s)
Aggressive Periodontitis/metabolism , Collagen/metabolism , Fibroblasts/metabolism , Gingiva/metabolism , Periodontitis/metabolism , Adolescent , Adult , Age Factors , Aged , Aggressive Periodontitis/pathology , Analysis of Variance , Carcinogens/pharmacology , Cells, Cultured , Child , Collagenases/metabolism , Disease Progression , Disease Susceptibility , Female , Gingiva/pathology , Humans , Interleukin-1/pharmacology , Male , Metalloendopeptidases/drug effects , Metalloendopeptidases/metabolism , Middle Aged , Periodontal Attachment Loss/metabolism , Periodontal Attachment Loss/pathology , Periodontitis/classification , Periodontitis/pathology , Regression Analysis , Tetradecanoylphorbol Acetate/pharmacology , Time Factors
20.
J Dent Res ; 76(6): 1260-70, 1997 Jun.
Article in English | MEDLINE | ID: mdl-9168859

ABSTRACT

A critical outcome of periodontal disease is degradation of the collagenous periodontal ligament that connects teeth to bone in the dental arch. Periodontal diseases occur in response to bacterial colonization of the teeth, but their molecular pathogenesis is still speculative. One family of enzymes, known as the matrix metalloproteinases (MMPs), has been implicated in the degradation of the periodontal ligament. MMPs, which are also suspected to play a role in many other physiologic and pathologic remodeling processes, can be secreted by epithelial cells surrounding the teeth and are found in relative abundance in tissues and fluids near periodontally diseased sites. Since most MMPs are secreted as inactive zymogens which may be activated by limited proteolysis, it has been suggested that proteinases expressed by the infecting periodontal pathogens might activate latent host MMPs to initiate or accelerate degradation of the collegenous periodontal ligament. The aim of this work was to examine interactions between purified host MMPs and bacterial proteinase. In this article, we demonstrate that a proteinase isolated from the periodontopathogen Porphyromonas gingivalis can activate MMP-1, MMP-3, and MMP-9 and can catalyze the superactivation of MMP-1 by MMP-3. Activation of these MMPs is demonstrated to result from initial hydrolysis within their propeptide. Also, for MMP-1 and MMP-9, the P. gingivalis proteinase cleaves the MMP propeptide following a lysine residue at a previously unreported site which, for both MMPs, is one residue NH2-terminal to the known autocatalytic cleavage site. These data describe a mode of virulence for the periodontopathogen Porphyromonas gingivalis that involves activation of host-degradative enzymes.


Subject(s)
Bacterial Proteins/metabolism , Cysteine Endopeptidases/metabolism , Extracellular Matrix Proteins/metabolism , Metalloendopeptidases/metabolism , Porphyromonas gingivalis/enzymology , Amino Acid Sequence , Collagenases/metabolism , Culture Media, Conditioned , Enzyme Activation , Glycoproteins/metabolism , Matrix Metalloproteinase 1 , Matrix Metalloproteinase 3/metabolism , Matrix Metalloproteinase 9 , Molecular Sequence Data , Porphyromonas gingivalis/pathogenicity , Protease Inhibitors/metabolism , Tissue Inhibitor of Metalloproteinases , Virulence
SELECTION OF CITATIONS
SEARCH DETAIL
...